Geoffrey Ling | |
---|---|
Born | Baltimore, Maryland |
Allegiance | United States of America |
Service | United States Army |
Years of service | 1985-2012 |
Rank | Colonel |
Battles / wars | War in Afghanistan (2003), Iraq War (2005) |
Alma mater | Washington University in St. Louis Cornell University Georgetown University |
Geoffrey S. F. Ling is a medical doctor who retired from the United States Army as a colonel and was the CEO of On Demand Pharmaceuticals. He served as the founding director of the Defense Advanced Research Projects Agency (DARPA) Biological Technologies Office from 2014 until 2016. [1] He was considered to be the "US Army's premier subject matter expert on traumatic brain injury (TBI)", and was for years the only neuro-intensive care specialist in the US military. [2]
Prominent in his DARPA research portfolio are Preventing Violent Explosive Neuro Trauma (PREVENT), prevention of explosive blast traumatic brain injury, [3] Revolutionizing Prostheses (RP), development of responsive, brain-controlled, artificial arms, Predicting Health and Disease (PHD), combination of biomarkers and advanced analytics to diagnosis of disease in the presymptomatic state and Battlefield Medicine, development of point-of-care drug manufacturing technology. He also served as a Program Manager and following, the deputy director of the Defense Sciences Office. Ling is recipient of the Department of Defense Medal for Distinguished Public Service, Legion of Merit, Alpha Omega Alpha, Sigma Xi and the Humanitarian Award from the Brain Mapping Foundation. [2] [4]
On May 21, 2018, HARPA (Health Advanced Research Projects Agency) was first publicly proposed on Fox Business News by Bob Wright and Geoff Ling . In April 2020, Ling co-wrote with Michael Stebbins the proposal for the creation this new federal agency modeled on DARPA, but focused on health. That proposal was adopted by then former Vice-President Biden's presidential campaign and published on line as part of the Day One Project. It became the model used to establish the Advanced Research Projects Agency for Health (ARPA-H).
Ling was born in Baltimore, MD to Alfred Ling, M.D, Ph.D. and Helen M. Ling, M.S. His father was a professor at Rockefeller University and a pharmaceutical executive. His mother was an aerospace engineer who worked on the U.S. space program. He is married to Shari Ling, M.D., the national Deputy Chief Medical Officer of the Centers for Medicare and Medicaid Services (CMS). [5]
Ling graduated from Stuyvesant High School in New York City. He earned his BA from Washington University in St. Louis, and earned his Ph.D. in pharmacology from Cornell University Graduate School of Medical Sciences (1982). He completed post doctoral training in Neuropharmacology at the Memorial Sloan Kettering Cancer Center (1982-1985). [6] In 1989, Ling earned an M.D. from Georgetown University School of Medicine. [3] Both his neurology internship (1989-1990) and later residency (1990-1993) were completed at Walter Reed Army Medical Center. From 1993 to 1995 Ling had a clinical fellowship at Johns Hopkins Hospital, Neurosciences Critical Care Unit. [6] At Cornell and Sloan-Kettering, he did opioid research. [7] [8]
Ling completed two war deployments as a neurointensive care physician: Afghanistan (2003) and Iraq (2005), as well as four "Gray Team" missions to study combat brain injuries. [9] [10] His medical studies of the war in Afghanistan and Iraq show that over 50% of those who died of wounds had head injuries. [11]
Prior to his position as the founding Director of the Biological Technologies Office at DARPA, Ling was Professor and Acting Chair of the Department of Neurology at the Uniformed Services University of the Health Sciences (USUHS). [9] He has been on the USUHS faculty since 1995 and is now Emeritus Professor. For many years, he was the Army's only neuro-intensive care physician. [2] [12] Ling is also Professor of Neurology and Anesthesiology & Critical Care Medicine at Johns Hopkins Hospital [13] . Ling served as an Army doctor for 27 years, and retired in 2012. Ling and his work have been featured twice on the TV show 60 Minutes , in 2009 and 2012. [14] [15]
Ling is Professor of Neurology, Neurosurgery and Anesthesiology & Critical Care Medicine at Johns Hopkins Hospital [13] and is a member of the neurosciences critical care unit (NCCU) clinical faculty. Ling and his work have been featured twice on the TV show 60 Minutes , in 2009 and 2012. [14] [15] He was also one of the doctors who treated American Congresswoman Gabby Giffords after she had been shot in the head. [2] Ling's publications include over 200 peer-reviewed journal articles, research reviews, and book chapters [9]
Because of engineering and medical concerns, arm replacement is more difficult than leg replacement. Arm replacement technology was far behind leg replacement technology when DARPA began the Revolutionizing Prosthetics team in 2006. In May 2014, the US Food and Drug Administration approved the first of the two prosthetic arms developed under that program. [16] [17] Earlier in 2014, DARPA's Biological Technologies Office announced the launch of a new Hand Proprioception and Touch Interfaces (HAPTIX) program, which aims to deliver naturalistic sensations to amputees and, in the process, enable intuitive, dexterous control of advanced prosthetic devices; provide the psychological benefit of improving prosthesis "embodiment"; and reduce phantom limb pain. Ling has described the problem of developing a high quality artificial arm as "doggone hard". [18] Ling's Revolutionizing Prosthetics team's work could lead to the restoration of sight and hearing. Using his artificial arms, amputees could precisely move their artificial arms with just thought. [14] [15]
Ling is board certified in both neurology and neurocritical care. Ling was an "A" designated Army neurologist and is a recipient of the Order of Military Medical Merit. [10] In Toronto, Canada, in 2012, Ling was awarded the Humanitarian Award from the Brain Mapping Foundation. [2] [4] He is a Fellow of the American Neurological Association, American Academy of Neurology and the Neurocritical Care Society. Named DARPA Program Manager of the Year (2008), Cornell University Alumnus of the Year (2008) and Washington University Distinguished Alumnus (2015). Is member of Alpha Omega Alpha and Sigma Xi. In 2016, he received the Department of Defense Medal for Distinguished Public Service. In 2022, he was conferred an honorary Doctor of Science (DSc) by the Elmezzi Graduate School of Molecular Medicine.
Uniformed Services University of the Health Sciences (USU) is a health science university and professional school of the U.S. federal government. The primary mission of the school is to prepare graduates for service to the U.S. at home and abroad as uniformed health professionals, scientists and leaders; by conducting cutting-edge, military-relevant research; by leading the Military Health System in key functional and intellectual areas; and by providing operational support to units around the world.
Brain implants, often referred to as neural implants, are technological devices that connect directly to a biological subject's brain – usually placed on the surface of the brain, or attached to the brain's cortex. A common purpose of modern brain implants and the focus of much current research is establishing a biomedical prosthesis circumventing areas in the brain that have become dysfunctional after a stroke or other head injuries. This includes sensory substitution, e.g., in vision. Other brain implants are used in animal experiments simply to record brain activity for scientific reasons. Some brain implants involve creating interfaces between neural systems and computer chips. This work is part of a wider research field called brain–computer interfaces.
The Doctor of Medicine–Doctor of Philosophy (MD–PhD) is a dual doctoral program for physician–scientists, combining the professional training of the Doctor of Medicine degree with the research program of the Doctor of Philosophy degree.
The Faculty of Medicine and Health Sciences is one of the constituent faculties of McGill University. It was established in 1829 after the Montreal Medical Institution was incorporated into McGill College as the college's first faculty; it was the first medical faculty to be established in Canada. The Faculty awarded McGill's first degree, and Canada's first medical degree to William Leslie Logie in 1833.
The National Institute of Mental Health and Neuro-Sciences is a medical institution in Bengaluru, India. NIMHANS is the apex centre for mental health and neuroscience education in the country. It is an Institute of National Importance operating autonomously under the Ministry of Health and Family Welfare. NIMHANS is ranked 4th best medical institute in India, in the current National Institutional Ranking Framework.
Georgetown University Medical Center is a Washington, D.C.–based biomedical research and educational organization affiliated with Georgetown University that is responsible for over 80% of the university's sponsored research funding and is led by Edward B. Healton, MD, the Executive Vice President for Health Sciences and Executive Dean of the School of Medicine.
Neurocritical care is a medical field that treats life-threatening diseases of the nervous system and identifies, prevents, and treats secondary brain injury.
Albert Gjedde: is a Danish-Canadian neuroscientist. He is Professor of Neurobiology and Pharmacology at the Faculty of Health Sciences and Center of Neuroscience at the University of Copenhagen. He is currently also Adjunct Professor of Neurology and Neurosurgery in the Department of Neurology, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Adjunct Professor of Radiology and Radiological Science in the Division of Nuclear Medicine, Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, US, Adjunct Professor of Translational Neuropsychiatry Research, University of Southern Denmark, Odense, Denmark, and adjunct professor of psychiatry at Tabriz University of Medical Sciences, Tabriz, East Azerbadjan, Iran.
The White House BRAIN Initiative is a collaborative, public-private research initiative announced by the Obama administration on April 2, 2013, with the goal of supporting the development and application of innovative technologies that can create a dynamic understanding of brain function.
Brain technology, or self-learning know-how systems, defines a technology that employs latest findings in neuroscience. [see also neuro implants] The term was first introduced by the Artificial Intelligence Laboratory in Zurich, Switzerland, in the context of the Roboy project. Brain Technology can be employed in robots, know-how management systems and any other application with self-learning capabilities. In particular, Brain Technology applications allow the visualization of the underlying learning architecture often coined as "know-how maps".
Rajiv Ratan is an Indian American academic, professor, administrator and scientist based in New York. He is the Burke Professor of Neurology and Neuroscience at Weill Cornell Medicine. Since 2003, he has served as the executive director of Burke Neurological Institute and as a member of the Council of Affiliated Deans of Weill Cornell Medicine.
The Neurocritical Care Society (NCS) is an international, multidisciplinary medical society first established in 2002. The Society is dedicated to improving the care and outcomes of patients with life-threatening neurologic illnesses in the intensive care unit. Common illnesses requiring neurocritical care include ischemic stroke, subarachnoid hemorrhage, intracranial hemorrhage, traumatic brain and spinal cord injury, coma, and status epilepticus. Its members are health professionals providing care to critically ill and injured patients. The Society supports research and education, and advocates on issues related to neurointensive care, neurocritical care, and general critical care.
Christian Macedonia is a medical doctor and a retired United States Army officer. From 2009 to 2011, he led the Gray Team which was tasked to improve the care of American forces serving in Iraq and Afghanistan.
Igor Koralnik is an American physician, neurologist and scientist. He is one of the first physicians to study the neurologic complications caused by the human immunodeficiency virus (HIV) and is a leading researcher in the investigation of the polyomavirus JC, which causes progressive multifocal leukoencephalopathy (PML), a disease of the central nervous system that occurs in immunosuppressed individuals.
The Biological Technologies Office (BTO) is one of the seven technical offices within DARPA, an agency of the U.S. Department of Defense that is responsible for the development of advanced technology for national security. BTO was created in 2014 by combining some programs from the Defense Sciences Office (DSO) and the Microsystems Technology Office (MTO). The office focuses on basic and applied research in the areas of gene editing, biotechnologies, neurosciences and synthetic biology — from powered exoskeletons for soldiers to brain implants that can control mental disorders.
The Montreal Neurological Institute-Hospital(MNI), also known as Montreal Neuro or The Neuro, is a research and medical centre dedicated to neuroscience, training and clinical care, located in the city's downtown core of Montreal, Quebec, Canada. It is part of the McGill University Health Centre network and it is situated on the southern slope of Mount Royal along the east side of University Street, just north of Pine Avenue. It was founded in 1934 by neurosurgeon Wilder Penfield, who developed the Montreal procedure there for the treatment of epilepsy.
Thomas J. Oxley is the chief executive officer of Synchron and neurointerventionist at Mount Sinai Hospital in New York City. Trained as a vascular and interventional neurologist, he established the Vascular Bionics laboratory at the University of Melbourne and is currently co-head of this lab. Oxley is best known for founding Synchron, a company building next-generation brain computer interface solutions that has recently announced the first clinical data on a novel stent electrode (Stentrode) neural interface that is inserted through blood vessels. The company was initiated sometime after his cold-call to DARPA for funding, and has received substantial funding from the U.S. Defense Advanced Research Projects Agency (DARPA) and the Australian government to research this minimally-invasive neural interface technology.
Sherry Hsiang-Yi Chou is a Canadian neurologist and an Associate Professor of Neurology and Chief of Neurocritical Care at the Northwestern University Feinberg School of Medicine and Northwestern Medicine. She is a Fellow of the Neurocritical Care Society and the Society of Critical Care Medicine. During the COVID-19 pandemic Chou assembled a worldwide team of physicians and scientists to better understand the neurological impacts of COVID-19, forming the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID). The first report of this large, multicenter, multicontinent consortium found that neurological manifestations are present in 8 out of 10 adult patients hospitalized with COVID-19 and are associated with increased mortality.
David Hillel Gutmann is an American neurologist-neuroscientist. He teaches at Washington University in St. Louis, where he is the Donald O. Schnuck Family Professor, and Director of the Washington University Neurofibromatosis Center. He is an international expert in Neurofibromatosis, pioneering the use of preclinical models to understand brain tumors and neurodevelopmental delays in children with NF1.
David Lozoff Brody is an American neurologist, academic, and author most known for his research on the clinical treatment of traumatic brain injury (TBI) and neurodegenerative diseases in civilian and military personnel. He is a Clinical Neurologist at the Walter Reed National Military Medical Center and a professor of Neurology at Uniformed Services University of the Health Sciences, as well as a professor of Neurology and Biomedical Engineering at Washington University.